ExeVir Bio Appoints a Chief Scientific Officer
Ghent, Belgium, 1 September 2023: ExeVir Bio, a biotech company developing robust single-domain antibody therapies for broad protection against infectious diseases, today announced Dr. Viki Bockstal as its Chief Scientific Officer (CSO) and Caroline Sagaert as its Head of Operations. Jean-Philippe Bultot will become the Company’s Head of Finance and lead ExeVir’s finance and accounting. Fiona du Monceau will step down as the current COO & CFO and joins the Company’s Board of Directors as an observer.
